Company profile for PACT Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PACT Pharma is an independent, privately funded company recently launched by Arcus and scientific founders Jim Heath (Caltech), Toni Ribas (UCLA) and David Baltimore (Caltech). PACT’s vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer. Our mission is to leverage technology developed in the laboratories of Jim Heath and David Baltimore to advance the feasibilit...
PACT Pharma is an independent, privately funded company recently launched by Arcus and scientific founders Jim Heath (Caltech), Toni Ribas (UCLA) and David Baltimore (Caltech). PACT’s vision is to be the leader in creating, developing and commercializing cell-based therapies for the cure of cancer. Our mission is to leverage technology developed in the laboratories of Jim Heath and David Baltimore to advance the feasibility, affordability and clinical utilization of personalized neoantigen-specific adoptive cell therapy for cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Corporate Drive, 2nd Floor South San Francisco, CALIFORNIA 94080
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/nature-paper-from-pact-pharma-and-ucla-highlights-how-patients-with-cancer-respond-differently-to-anti-pd-1-therapy-301765945.html

PR NEWSWIRE
08 Mar 2023

https://www.fiercebiotech.com/research/pact-pharma-establishes-safety-complex-crispr-t-cell-receptor-therapy

Helen Floersh FIERCEBIOTECH
15 Nov 2022

https://www.prnewswire.com/news-releases/pact-pharma-to-present-new-data-highlighting-first-of-its-kind-personalized-neoantigen-tcr-t-cell-therapy-platform-at-sitc-2022-301665733.html

PRNEWSWIRE
02 Nov 2022

https://www.biospace.com/article/releases/pact-pharma-announces-agreement-to-sell-select-assets-to-amplifybio/?s=79

BIOSPACE
03 Oct 2022

https://www.fiercebiotech.com/biotech/pact-unveils-teased-bd-venture-sells-select-assets-and-south-san-francisco-facility

Max Bayer FIERCEBIOTECH
03 Oct 2022

https://www.fiercebiotech.com/biotech/fractured-pact-pharma-lays-additional-51-staffers-suspends-phase-1-trial-company-struggles

Max Bayer FIERCEBIOTECH
25 Aug 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty